Impact of Conflict on Mpox Testing in the DRC
The Democratic Republic of Congo is experiencing a critical drop in its mpox testing rate, which has plummeted to just 17% in the past week. Dr. Ngashi Ngongo from the Africa CDC attributes this downturn to the compounded challenges of ongoing conflict and a freeze on aid, particularly from the United States, which is crucial for specimen transportation.
Efforts to decentralize laboratory services have expanded the number of laboratories significantly, from two to 21 since last July. However, the ambitious goal to reach 56 laboratories remains unmet due to continued unrest, particularly in the eastern regions (Ngashi, 2025). The widespread displacement of over two million people further hinders health services, leading to calls for humanitarian corridors to restore essential health infrastructure in regions overtaken by M23 rebels.
Vaccination Efforts in Kinshasa
Despite these challenges, there has been a promising development in Kinshasa, where vaccination efforts have led to over 300,000 individuals being vaccinated against mpox, meeting more than half of the target set by health authorities. This success story is attributed to a strategic pivot in focus from targeted populations to addressing geographic hotspots (Ngashi, 2025).
However, a new variant of mpox, Clade 1A, identified in Kinshasa, mirrors a gene found in the more transmissible Clade 1B, raising concerns about potential increases in infectiousness. Continuous monitoring and quick adaptation of public health strategies are now more critical than ever (Ngashi, 2025).
Uganda‘s Emerging Ebola Cases: A New Concern
Meanwhile, Uganda reports five Ebola cases, with three confirmed and two provisional. This new outbreak, beginning with a four-year-old child, seems unrelated to a prior outbreak, though genomic tests suggest it involves the same strain. Investigations are underway to uncover the index case, possibly unrelated to typical animal transmission, challenging health officials to adapt and respond effectively (Ngashi, 2025).
This situation amplifies the need for robust epidemiological surveillance and swift multidisciplinary interventions that can address potential anomalies quickly and prevent wider outbreaks.
Conclusion and Future Trends
Both situations in the DRC and Uganda highlight the complex interplay of conflict, public health infrastructure, and disease surveillance. Going forward, integrating technological advancements, like digital tracking of specimen logistics and vaccination records, can support more robust public health responses (International Health Organization, 2025).
The international community’s role in supporting these efforts becomes indispensable. Health policy and strategic global investments will need to account for the specific challenges presented by conflict zones and rapidly evolving pathogen dynamics.
FAQ Section
Q: What is the significance of decentralizing laboratory services in DRC?
A: It provides on-ground testing facilities, reducing transport delays and making diagnosis faster, crucial for effective disease control (Ngashi, 2025).
Q: How does the new mpox variant affect public health strategies?
A: Public health strategies must be agile and preemptive, potentially including adjusted vaccination formulations and health advisories to curb increased spread risks.
Call-to-Action
For more insightful breakdowns of global health challenges, subscribe to our newsletter. Join the conversation and share your thoughts in the comment section below.
